Table 2 Antibiotic susceptibility results of pneumococcal isolates from children with invasive pneumococcal disease
Antibiotica | No. of isolates (%)b | Total no. of isolates | |||
|---|---|---|---|---|---|
Susceptible | Intermediate | Resistant | Nonsusceptible (R + I) | ||
Penicillin | |||||
Meningitisc | 16(28.1) | 0 | 41(71.9) | 41 (71.9) | 57 |
Nonmeningitis | 67 (51.9) | 51 (39.5) | 11 (8.5) | 62 (48.1) | 129 |
Cefotaxime | |||||
Meningitisc | 17 (35.4) | 23 (47.9) | 8 (16.7) | 31 (64.6) | 48 |
Nonmeningitis | 74 (61.7) | 27 (22.5) | 19 (15.8) | 46 (37.5) | 120 |
Cefepime | |||||
Meningitisc | 10 (23.8) | 12 (28.6) | 20 (47.7) | 32 (76.2) | 42 |
Nonmeningitis | 49 (49.5) | 42 (42.4) | 8 (19.0) | 50 (50.1) | 99 |
Erythromycin | 4 (2.6) | 0 | 152 (97.4) | 152 (97.4) | 156 |
Clindamycin | 4 (2.6) | 0 | 149 (97.4) | 149 (97.4) | 153 |
Tetracycline | 14 (9.0) | 14 (9.0) | 128 (82.1) | 128 (91.0) | 156 |
SMZ-Co | 47 (26.3) | 22 (12.3) | 110 (61.5) | 110 (73.7) | 179 |
Chloramphenicol | 166 (93.3) | 0 | 12 (6.7) | 12 (6.7) | 178 |
Levofloxacin | 155 (100.0) | 0 | 0 | 0 (0) | 155 |
Meropenem | 39 (39.0) | 35 (35.0) | 26 (26.0) | 61 (61) | 100 |
Vancomycin | 181 (100.0) | 0 | 0 | 0 (0) | 181 |
Linezolid | 181 (100.0) | 0 | 0 | 0 (0) | 181 |